Last Update: Feb 28, 2024
A Randomized, Controlled, Open Label, Phase III Study Evaluating the Efficacy and Safety of JDQ443 Versus Docetaxel in Previously Treated Subjects With Locally Advanced or Metastatic KRAS G12C Mutant Non-small Cell Lung Cancer
ClinicalTrials.gov Identifier:
Novartis Reference Number:CJDQ443B12301
All compounds are either investigational or being studied for (a) new use(s). Efficacy and safety have not been established. There is no guarantee that they will become commercially available for the use(s) under investigation.

Study Description

This is a phase III randomized open label study designed to compare JDQ443 as monotherapy to docetaxel in participants with advanced non-small cell lung cancer (NSCLC) harboring a KRAS G12C mutation who have been previously treated with a platinum-based chemotherapy and immune checkpoint inhibitor therapy either in sequence or in combination.

The study has been designed as a Phase III trial and consists of 2 parts:

Randomized part will evaluate the efficacy and safety of JDQ443 as monotherapy in comparison with docetaxel. Participants randomized to docetaxel arm will have the opportunity to cross-over to JDQ443 at disease progression per RECIST 1.1 confirmed by BIRC.
Extension part will be open after final progression-free survival (PFS) analysis (if the primary endpoint has met statistical significance) to allow participants randomized to docetaxel treatment to crossover to receive JDQ443 treatment regardless of progression on docetaxel.

The study population will include adult participants with locally advanced or metastatic (stage IIIB/IIIC or IV) KRAS G12C mutant non-small cell lung cancer (by tissue or plasma as determined by a Novartis-designated central laboratory or accepted local tests) who have received prior platinum-based chemotherapy and prior immune checkpoint inhibitor therapy administered either in sequence or as combination therapy.

Approximately 360 participants will be randomized to JDQ443 or docetaxel in a 1:1 ratio stratified by prior line of therapy and ECOG performance status.

Non-Small Cell Lung Cancer
Phase 3
Recruiting
360
Jun 15, 2022
Dec 31, 2025
All
18 Years - (Adult, Older Adult)

Interventions

Drug

docetaxel

docetaxel concentrated solution for infusion, intravenously administered
Drug

JDQ443

JDQ443 tablets, orally administered

Eligibility Criteria

Inclusion Criteria:

Participant has histologically confirmed locally advanced/metastatic (stage IIIB/IIIC or IV)
Participant has a KRAS G12C mutation present in tumor tissue or plasma prior to enrollment, as determined by a Novartis designated central laboratory or by accepted local tests.
Participants has received one prior platinum-based chemotherapy regimen and one prior immune checkpoint inhibitor therapy for locally advanced or metastatic disease
Participant has at least 1 evaluable (measurable or non-measurable) lesion by RECIST 1.1 at the screening visit.

Exclusion Criteria:

Participants who have previously received docetaxel (except if received in neoadjuvant or adjuvant setting with no progression within 12 months after the of end of treatment), or any other KRAS G12C inhibitor.
Participant has EGFR-sensitizing mutation and/or ALK rearrangement by local laboratory testing. Participants with other druggable alterations will be excluded if required by local guidelines.
Participant has known active central nervous system (CNS) metastases and/or carcinomatous meningitis
Participant has an history of interstitial lung disease or pneumonitis grade > 1.

Other inclusion/exclusion criteria may apply

Study Location

Novartis Investigative Site

Recruiting

Cordoba,X5000JHQ,Argentina

Novartis Investigative Site

Recruiting

La Plata,Buenos Aires,B1900AWT,Argentina

Novartis Investigative Site

Recruiting

Buenos Aires,C1431FWO,Argentina

Novartis Investigative Site

Recruiting

Pilar,Buenos Aires,B1629AHJ,Argentina

Novartis Investigative Site

Recruiting

Caba,Buenos Aires,C1414DRK,Argentina

Novartis Investigative Site

Recruiting

South Brisbane,Queensland,4101,Australia

Novartis Investigative Site

Recruiting

Auchenflower,Queensland,4066,Australia

Novartis Investigative Site

Recruiting

Southport,Queensland,4215,Australia

Novartis Investigative Site

Recruiting

Hyde Park,Queensland,4812,Australia

Novartis Investigative Site

Recruiting

Rio de Janeiro,RJ,22640-000,Brazil

Novartis Investigative Site

Recruiting

Rio Grande Do Sul,90035-001,Brazil

Novartis Investigative Site

Recruiting

Ijuí,RS,98700-000,Brazil

Novartis Investigative Site

Recruiting

Sao Paulo,01509-010,Brazil

Novartis Investigative Site

Recruiting

Sao Paulo,SP,01308-050,Brazil

Novartis Investigative Site

Recruiting

Sofia,1303,Bulgaria

Novartis Investigative Site

Recruiting

Russe,7002,Bulgaria

Novartis Investigative Site

Recruiting

Plovdiv,4004,Bulgaria

Novartis Investigative Site

Recruiting

Sherbrooke,Quebec,J1H 5N4,Canada

Novartis Investigative Site

Recruiting

Levis,Quebec,G6V 3Z1,Canada

Novartis Investigative Site

Recruiting

Montreal,Quebec,H4A 3J1,Canada

Novartis Investigative Site

Recruiting

Santiago,Region Metropolitana,7560908,Chile

Novartis Investigative Site

Recruiting

Changsha,Hunan,410013,China

Novartis Investigative Site

Recruiting

Harbin,Heilongjiang,150081,China

Novartis Investigative Site

Recruiting

Jinan,Shandong,250117,China

Novartis Investigative Site

Recruiting

Guangzhou,Guangdong,51000,China

Novartis Investigative Site

Recruiting

Chengdu,Sichuan,610041,China

Novartis Investigative Site

Recruiting

Wuhan,Hubei,430022,China

Novartis Investigative Site

Recruiting

Hefei,Anhui,230001,China

Novartis Investigative Site

Recruiting

Nanjing,Jiangsu,210008,China

Novartis Investigative Site

Recruiting

Guangzhou,Guangdong,510080,China

Novartis Investigative Site

Recruiting

Chongqing,400042,China

Novartis Investigative Site

Recruiting

Wuhan,Hubei,430060,China

Novartis Investigative Site

Recruiting

Beijing,100036,China

Novartis Investigative Site

Recruiting

Hangzhou,Zhe Jiang,310003,China

Novartis Investigative Site

Recruiting

Hangzhou,Zhejiang,310022,China

Novartis Investigative Site

Recruiting

Beijing,100730,China

Novartis Investigative Site

Recruiting

Shanghai,200025,China

Novartis Investigative Site

Recruiting

Fuzhou,Fujian,350014,China

Novartis Investigative Site

Recruiting

Zhengzhou,450008,China

Novartis Investigative Site

Recruiting

Shenzhen,Guangdong,518000,China

Novartis Investigative Site

Recruiting

Medellin,Antioquia,050001,Colombia

Novartis Investigative Site

Recruiting

Valledupar,Cesar,5602310,Colombia

Novartis Investigative Site

Recruiting

Monteria,230004,Colombia

Novartis Investigative Site

Recruiting

Zagreb,10000,Croatia

Novartis Investigative Site

Recruiting

Ostrava Vitkovice,703 84,Czech Republic

Novartis Investigative Site

Recruiting

Odense C,DK 5000,Denmark

Novartis Investigative Site

Recruiting

Tartu,50406,Estonia

Novartis Investigative Site

Recruiting

Turku,FI-20521,Finland

Novartis Investigative Site

Recruiting

Vaasa,65130,Finland

Novartis Investigative Site

Recruiting

Athens,11526,Greece

Novartis Investigative Site

Recruiting

Athens,GR,115 27,Greece

Novartis Investigative Site

Recruiting

Heraklion Crete,711 10,Greece

Novartis Investigative Site

Recruiting

Thessaloniki,54622,Greece

Novartis Investigative Site

Recruiting

Hong Kong,999077,Hong Kong

Novartis Investigative Site

Recruiting

Shatin New Territories,Hong Kong

Novartis Investigative Site

Recruiting

Budapest,1121,Hungary

Novartis Investigative Site

Recruiting

Torokbalint,Pest,2045,Hungary

Novartis Investigative Site

Recruiting

Reykjavik,IS-101,Iceland

Novartis Investigative Site

Recruiting

Bangalore,Karnataka,560076,India

Novartis Investigative Site

Recruiting

Hyderabad,Andhra Pradesh,500 034,India

Novartis Investigative Site

Recruiting

Mumbai,400 012,India

Novartis Investigative Site

Recruiting

Nashik,Maharashtra,422 004,India

Novartis Investigative Site

Recruiting

Kolkata,West Bengal,700160,India

Novartis Investigative Site

Recruiting

Delhi,110 085,India

Novartis Investigative Site

Recruiting

Visakhapatnam,Andhrapradesh,530017,India

Novartis Investigative Site

Recruiting

Jaipur,Rajasthan,302019,India

Novartis Investigative Site

Recruiting

Lucca,LU,55100,Italy

Novartis Investigative Site

Recruiting

Roma,RM,00128,Italy

Novartis Investigative Site

Recruiting

Aviano,PN,33081,Italy

Novartis Investigative Site

Recruiting

Amman,1857,Jordan

Novartis Investigative Site

Recruiting

Irbid,22110,Jordan

Novartis Investigative Site

Recruiting

Amman,11941,Jordan

Novartis Investigative Site

Recruiting

Seoul,05030,Korea, Republic of

Novartis Investigative Site

Recruiting

Seoul,05505,Korea, Republic of

Novartis Investigative Site

Recruiting

Jinju,660-702,Korea, Republic of

Novartis Investigative Site

Recruiting

Seoul,Korea,08308,Korea, Republic of

Novartis Investigative Site

Recruiting

Seoul,Seocho Gu,06591,Korea, Republic of

Novartis Investigative Site

Recruiting

Busan,49241,Korea, Republic of

Novartis Investigative Site

Recruiting

Daegu,Dalseo Gu,42602,Korea, Republic of

Novartis Investigative Site

Recruiting

Seongnam Si,Gyeonggi Do,13620,Korea, Republic of

Novartis Investigative Site

Recruiting

Ashrafieh,166830,Lebanon

Novartis Investigative Site

Recruiting

Beirut,1107 2020,Lebanon

Novartis Investigative Site

Recruiting

Saida,652,Lebanon

Novartis Investigative Site

Recruiting

Dora,90375,Lebanon

Novartis Investigative Site

Recruiting

Kuching,Sarawak,93586,Malaysia

Novartis Investigative Site

Recruiting

Petaling Jaya,Selangor Darul Ehsan,46150,Malaysia

Novartis Investigative Site

Recruiting

Petaling Jaya,Selangor,46050,Malaysia

Novartis Investigative Site

Recruiting

Kuala Lumpur,59100,Malaysia

Novartis Investigative Site

Recruiting

Guadalajara,Jalisco,44280,Mexico

Novartis Investigative Site

Recruiting

Cuautitlan Izcalli,Estado De Mexico,54769,Mexico

Novartis Investigative Site

Recruiting

Mexico City,06760,Mexico

Novartis Investigative Site

Recruiting

Veracruz,91900,Mexico

Novartis Investigative Site

Recruiting

Drammen,3004,Norway

Novartis Investigative Site

Recruiting

Trondheim,7006,Norway

Novartis Investigative Site

Recruiting

Warszawa,02 781,Poland

Novartis Investigative Site

Recruiting

Rzeszow,35-055,Poland

Novartis Investigative Site

Recruiting

Matosinhos,4454 513,Portugal

Novartis Investigative Site

Recruiting

Lisboa,1998-018,Portugal

Novartis Investigative Site

Recruiting

Porto,4100-180,Portugal

Novartis Investigative Site

Recruiting

Bucharest,022328,Romania

Novartis Investigative Site

Recruiting

Iasi,700483,Romania

Novartis Investigative Site

Recruiting

Craiova,Dolj,200347,Romania

Novartis Investigative Site

Recruiting

Cluj Napoca,400058,Romania

Novartis Investigative Site

Recruiting

Floresti,Cluj,407280,Romania

Novartis Investigative Site

Recruiting

Cluj-Napoca,400124,Romania

Novartis Investigative Site

Recruiting

Alba Iulia,Alba,510077,Romania

Novartis Investigative Site

Recruiting

Constanta,905900,Romania

Novartis Investigative Site

Recruiting

Timisoara,300425,Romania

Novartis Investigative Site

Recruiting

Belgrade,11000,Serbia

Novartis Investigative Site

Recruiting

Golnik,4204,Slovenia

Novartis Investigative Site

Recruiting

Ljubljana,1000,Slovenia

Novartis Investigative Site

Recruiting

Pamplona,Navarra,31008,Spain

Novartis Investigative Site

Recruiting

Madrid,28009,Spain

Novartis Investigative Site

Recruiting

La Coruna,Galicia,15006,Spain

Novartis Investigative Site

Recruiting

Alicante,Comunidad Valenciana,03010,Spain

Novartis Investigative Site

Recruiting

Badalona,Catalunya,08916,Spain

Novartis Investigative Site

Recruiting

Oviedo,Asturias,33011,Spain

Novartis Investigative Site

Recruiting

Cordoba,Andalucia,14004,Spain

Novartis Investigative Site

Recruiting

Tainan,70403,Taiwan

Novartis Investigative Site

Recruiting

Taipei,103616,Taiwan

Novartis Investigative Site

Recruiting

Taoyuan,33305,Taiwan

Novartis Investigative Site

Recruiting

Bangkok,10330,Thailand

Novartis Investigative Site

Recruiting

Bangkok,10700,Thailand

Novartis Investigative Site

Recruiting

Khon Kaen,THA,40002,Thailand

Novartis Investigative Site

Recruiting

Sakarya,54290,Turkey

Novartis Investigative Site

Recruiting

Fatih,34093,Turkey

Novartis Investigative Site

Recruiting

Ankara,06100,Turkey

Novartis Investigative Site

Recruiting

Cankaya Ankara,06560,Turkey

Novartis Investigative Site

Recruiting

Adana,01140,Turkey

Novartis Investigative Site

Recruiting

Ankara,06680,Turkey

Novartis Investigative Site

Recruiting

Istanbul,34662,Turkey

Novartis Investigative Site

Recruiting

Ankara,Yenimahalle,06200,Turkey

Novartis Investigative Site

Recruiting

Istanbul,34890,Turkey

Novartis Investigative Site

Recruiting

Antalya,07059,Turkey

Novartis Investigative Site

Recruiting

Staffordshire,WS11 5XY,United Kingdom

Novartis Investigative Site

Recruiting

Stoke on Trent,Staffordshire,ST46QG,United Kingdom

Exeter Hospital

Recruiting

Exeter,Julie Bushey email: [email protected] -- Panos Fidias,03833 - New Hampshire,United States

Hope And Healing Care Research

Recruiting

Hinsdale,Praneetha Achanta email: [email protected] -- Srilata Gundala,60521 - Illinois,United States

Mid Florida Hematology And Onc Ctr

Recruiting

Orange,Amanda Wise (386-774-1223) email: [email protected] -- Santosh Nair,32763 - Florida,United States

Valley Medical Center Research Valley Professional Center Bld

Recruiting

Renton,Melissa Bennett email: [email protected] -- Navanshu Arora,98055 - Washington,United States

Clinical Research Alliance Research

Recruiting

Lake Success,Krishna Pandit (+1 516 488 2918#183) email: [email protected] -- James D Olimpio,11042 - New York,United States

Novartis Investigative Site

Recruiting

Ho Chi Minh,700000,Vietnam

Novartis Investigative Site

Recruiting

Hanoi,300000,Vietnam

Worldwide Contacts

If the location of your choosing does not feature any contact detail, please reach out using the information below.

Novartis Pharmaceuticals

Novartis Pharmaceuticals